tm logo

Monitor this mark

View On USPTO

XERIS PHARMACEUTICALS
Live/Registered
REGISTERED

on 19 May 2020

Last Applicant/ Owned by

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810

Chicago

IL

60601

Serial Number

87450239 filed on 15th May 2017

Registration Number

6059089 registered on 19th May 2020

in the Principal Register

Correspondent Address

Tracy-Gene G. Durkin

Tracy-Gene G. Durkin

1100 New York Avenue, NW

Washington DC 20005

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XERIS PHARMACEUTICALS

Pharmaceutical preparations for the treatment of diseases and conditions, namely, metabolic and autoimmune diseases and conditions

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of diseases and conditions, namely, metabolic and autoimmune diseases and conditions

First Use Date in General

04th Nov 2019

First Use Date in Commerce

04th Nov 2019

Mark Details

Serial Number

No 87450239

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4605.0580000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Jun 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
19th May 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22nd May 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22nd May 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd May 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd May 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22nd May 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
19th May 2020REGISTERED-PRINCIPAL REGISTER
15th Apr 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14th Apr 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED